Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E19.72 EPS (ttm)1.58 Insider Own0.02% Shs Outstand6.30B Perf Week2.33%
Market Cap196.27B Forward P/E13.99 EPS next Y2.23 Insider Trans-6.39% Shs Float6.30B Perf Month6.53%
Income10.46B PEG15.77 EPS next Q0.53 Inst Own72.00% Short Float1.02% Perf Quarter6.90%
Sales50.05B P/S3.92 EPS this Y37.50% Inst Trans-0.58% Short Ratio2.60 Perf Half Y6.68%
Book/sh12.32 P/B2.53 EPS next Y-0.93% ROA18.70% Target Price34.19 Perf Year1.14%
Cash/sh5.31 P/C5.87 EPS next 5Y1.25% ROE41.80% 52W Range27.27 - 32.11 Perf YTD5.27%
Dividend1.04 P/FCF21.62 EPS past 5Y6.80% ROI10.50% 52W High-2.98% Beta0.69
Dividend %3.34% Quick Ratio2.50 Sales past 5Y1.30% Gross Margin80.90% 52W Low14.22% ATR0.45
Employees77700 Current Ratio2.90 Sales Q/Q-2.20% Oper. Margin32.90% RSI (14)72.39 Volatility1.76% 1.39%
OptionableYes Debt/Eq0.48 EPS Q/Q7.70% Profit Margin64.40% Rel Volume0.82 Prev Close31.10
ShortableYes LT Debt/Eq0.41 EarningsOct 28 BMO Payout21.10% Avg Volume24.59M Price31.15
Recom2.30 SMA202.98% SMA505.85% SMA2005.16% Volume20,278,608 Change0.16%
Jul-02-13Downgrade Standpoint Research Hold → Sell $24
Apr-15-13Reiterated Barclays Equal Weight $25 → $32
Jan-30-13Reiterated UBS Buy $29 → $31
Jan-30-13Reiterated Argus Buy $28 → $32
Jan-22-13Reiterated Barclays Equal Weight $24 → $25
Nov-27-12Downgrade MKM Partners Buy → Neutral $29 → $25
Oct-05-12Reiterated MKM Partners Buy $27 → $29
Nov-01-11Downgrade Standpoint Research Buy → Hold
Oct-07-11Initiated MKM Partners Buy $20.50
Sep-14-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
Aug-10-11Upgrade Argus Hold → Buy $21
Aug-05-11Upgrade Standpoint Research Hold → Buy $21
Mar-14-11Downgrade Standpoint Research Buy → Hold
Nov-03-10Downgrade Argus Buy → Hold
May-21-10Initiated Jefferies Buy $17.80
Dec-16-09Initiated UBS Buy
Apr-27-09Initiated Standpoint Research Buy $20
Feb-12-09Upgrade Leerink Swann Mkt Perform → Outperform
Feb-09-09Upgrade UBS Neutral → Buy
Feb-02-09Upgrade Credit Suisse Neutral → Outperform
Nov-28-14 02:45AM  I'm a strong believer in Europe: Astrazeneca CEO CNBC
02:45AM  Drug pipeline strong, less need for M&A: Astrazeneca CEO CNBC
02:30AM  Astrazeneca could eye tech firms for M&A: Expert CNBC
01:05AM  Pfizer deal would have failed: Astrazeneca CEO CNBC
01:01AM  Pfizer deal probably 'would have fallen apart': AZ CEO at CNBC
Nov-26-14 03:40PM  Intra-Cellular Commences Phase III Schizophrenia Study Zacks
06:00AM  These 5 Big Dividend Stocks Want to Pay You More: Pfizer, Coke and More at TheStreet
04:35AM  Pfizer to join forces with AstraZeneca? CNBC
03:34AM  Back for more: Will Pfizer top its AstraZeneca bid? at CNBC
01:20AM  Pfizer to renew pursuit of AstraZeneca? CNBC
Nov-25-14 09:02AM  AstraZeneca comes into focus as Pfizer's cooling-off period ends at Financial Times
Nov-24-14 10:57AM  Buying Glaxo's Biotech Stock Throwbacks Proves Profitable Yahoo Finance Blogs
Nov-22-14 05:00AM  Motley Fool: Pundits pandering your wealth away at USA TODAY
Nov-21-14 08:13AM  Do The IMPROVE-IT Results Offer Promise For Anacetrapib, Another Merck Heart Drug? at Forbes
Nov-20-14 12:19PM  Apple, Pfizer, GM and other financial turkeys of 2014 at Fortune
Nov-19-14 02:35PM  Will The IMPROVE-IT Results Impact The Thinking Of The FDA And Payers On LDL-Cholesterol Lowering Drugs? at Forbes
11:07AM  Stocks Boosted by Merck's Vytorin Data at Barrons.com
Nov-18-14 05:15PM  Merck KGaA Ties Up with Pfizer on Immuno-oncology Deal Zacks
12:23PM  AstraZeneca fleshes out standalone strategy at Financial Times
11:54AM  AstraZenecas Soriot Asks for Patience as Pfizer Return Looms at Bloomberg
09:38AM  AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer Reuters
08:30AM  TRUMENBA® (Meningococcal Group B Vaccine) is Now Available Business Wire
07:15AM  Are consumers getting gouged on health-care? at MarketWatch
03:44AM  Neil Woodford says belief in independent AstraZeneca "even stronger" Reuters
02:20AM  AstraZeneca trumpets progress in cancer, other drugs Reuters
Nov-17-14 05:16PM  Allergan Sides With More Aggressive Dealmaker By Picking Actavis Over Valeant at Forbes
04:56PM  The Top Ten Stocks for Nov. 17 at Bloomberg
04:00PM  Stocks little moved; S&P 500 at record-high close at CNBC
03:51PM  US, German drugmakers team up on cancer medicines AP
02:04PM  Will Lower Guidance Hurt Pfizer (PFE) Stock Today? at TheStreet
01:35PM  Merck Drug Works: Vytorin Study Proves Successful at Investor's Business Daily
12:35PM  Zoetis attractive & durable: Pro CNBC
11:47AM  Cramer: Pfizer Deal With Merck Leaves AstraZeneca in the Cold at TheStreet
11:05AM  Pfizer, Germanys Merck strike deal to develop cancer tumor treatment at MarketWatch
10:40AM  Allergan Agrees To $219 A Share Actavis Takeover Over Bill Ackman-Backed Valeant Deal at Forbes
10:23AM  [video]Pfizer Is Set to Buy Merck Cancer Drug Rights for $850 Million at TheStreet
10:17AM  [$$] Pfizer, Germany's Merck to Develop Tumor Treatment at The Wall Street Journal
10:04AM  Pfizer Strikes Pact with Merck After Abandoning AstraZeneca TheStreet
10:04AM  Pfizer Strikes Immuno-oncology Pact with Merck After Abandoning AstraZeneca at TheStreet
09:55AM  Cramer's Stop Trading: Hotel caution? CNBC
09:24AM  Cramer's Mad Dash: Pfizer's direction CNBC
09:16AM  Allergan and Actavis close to deal; Halliburton and Baker Hughes make it official; DreamWorks tumbles as Hasbro talks flop Hot Stock Minute
08:52AM  Pfizer says deal makes it 'competitive' in immuno-oncology Reuters
08:37AM  Urban Outfitters, Agilent, Allergan, Baker Hughes in focus Monday at MarketWatch
08:04AM  Pfizer's stock drops after profit outlook cut at MarketWatch
08:00AM  Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban) GlobeNewswire
07:49AM  Pfizer to pay up to $2 billion for cancer alliance with Germanys Merck at Fortune
05:37AM  Pfizer dampens Astra bid hopes with German Merck cancer deal Reuters
03:06AM  Pfizer to Buys Merck KGaA Cancer Drug Rights at Bloomberg
02:53AM  Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology Business Wire
Nov-16-14 07:01PM  Corruption tars drug industry drive to improve access for poor Reuters
Nov-14-14 06:17PM  [$$] Zoetis Adopts 'Poison Pill' Defense at The Wall Street Journal
01:04PM  PFIZER INC Financials EDGAR Online Financials
09:38AM  Report: Pfizer 'Unlikely' To Pursue Acquisition Of AstraZeneca Benzinga
07:46AM  AstraZeneca not only game in town for deal-hungry Pfizer Reuters
05:50AM  Why you should favor large-cap stocks for the next six weeks at MarketWatch
Nov-13-14 11:00AM  Novel Agreement Expands Access to Pfizers Contraceptive, Sayana® Press, for Women Most in Need in the Worlds Poorest Countries Business Wire
10:55AM  Pfizer, Gates Foundation, expand contraceptive access in poor nations Reuters
08:39AM  Pharmalot, Pharmalittle: We're Reading About Valeant, Pfizer and Lots More!! at The Wall Street Journal
Nov-12-14 04:46PM  Billionaire Bill Ackman's Valeant Trade Keeps Expanding With Zoetis at Forbes
02:47PM  SAC's Martoma loses bid for bail during insider trading appeal Reuters
01:38PM  [video]Activists Pershing Square and Starboard Go After Zoetis, Yahoo! at TheStreet
11:49AM  Ackman and a Former Protege Launch Campaign at Zoetis at TheStreet
11:13AM  Ackman Takes Stake in Animal-Health Company Zoetis at MarketWatch
08:00AM  Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting Business Wire
Nov-11-14 06:00PM  Cramer: Tuesday all about consolidation CNBC
10:26AM  Why Pfizer Is At A Technical 'Fork In The Road' Benzinga
Nov-10-14 04:24PM  [video] The Top Ten Stocks for Nov. 10 at Bloomberg
01:40PM  Will Puma Biotechnology (PBYI) Disappoint this Earnings? Zacks
01:34PM  Business events scheduled for Tuesday AP
Nov-08-14 07:07PM  10-Q for Pfizer Inc. Company Spotlight
Nov-06-14 06:41PM  Will Pfizer Sweeten Its Bid For AstraZeneca? at Investor's Business Daily
05:04PM  PFIZER INC Files SEC form 10-Q, Quarterly Report EDGAR Online
03:33PM  This investor went from hedge fund to franchisee at CNBC
11:41AM  Europe closes mixed after ECB's Draghi speech at CNBC
09:58AM  Republican-Controlled Congress Won?t Halt Wall Street?s Run Higher at Fox Business
07:46AM  AstraZeneca touts independence as Nexium drug keeps on giving Reuters
06:35AM  AstraZeneca Is Building Value Without Pfizer, CEO Says at Bloomberg
06:06AM  Pfizer's India unit reports Q2 loss on plant lockout costs Reuters
05:37AM  Tax changes weaken case for new Pfizer bid, says AstraZeneca CEO Reuters
04:07AM  AstraZeneca promotes standalone prospects at Financial Times
02:35AM  AstraZeneca CEO: Tax benefits for Pfizer of bid gone at CNBC
Nov-05-14 07:13PM  Ex-Ameriprise broker pleads guilty after SEC insider trading case Reuters
06:26PM  Monotype Gets Its Font Tech Deeper Into Advertising at Investor's Business Daily
12:00PM  GOP sweep playbook CNBC
11:00AM  Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference Business Wire
Nov-04-14 02:13PM  VRX, CELG And PFE, Pushing Drugs Industry Downward at TheStreet
08:49AM  High Drug Prices And Innovation at Forbes
Nov-03-14 01:47PM  Minerals Technologies Digs Up A Winner With Buyout at Investor's Business Daily
08:52AM  Debate: Do High Drug Prices Drive Innovation, Or Hurt It? at Forbes
06:35AM  Investors see green in Ireland CNBC
Oct-31-14 04:10PM  Will Zoetis (ZTS) Pull a Surprise this Earnings Season? Zacks
Oct-30-14 05:04PM  Pfizer's Trumenba Gains Accelerated Approval in the U.S. Zacks
03:00PM  Viagra's Come-Hither Ad Campaign at BusinessWeek
12:03PM  U.S. SEC wants to distribute $602 mln SAC settlement to victims Reuters
09:00AM  Would Disney spin off Disneyland? Corporate breakup talk 'jumps the shark' Yahoo Finance
Oct-29-14 06:34PM  F.D.A. Approves Pfizers Trumenba, a Vaccine for a Rare Meningitis at New York Times
04:30PM  Stocks end modestly lower as Fed pulls plug on QE at CNBC
04:16PM  Pfizer meningitis vaccine wins U.S. approval Reuters
02:44PM  Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults Business Wire
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products. The company's Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company's Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company also offers Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It serves wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. It has strategic alliance with CliniWorks (Israel) Ltd. to develop population health management platform with advanced analytics and patient care capabilities. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HILL CHARLES HExecutive Vice PresidentNov 10Sale30.188,285250,04199,478Nov 10 05:34 PM
YOUNG JOHN DGroup PresidentNov 07Option Exercise26.2021,600565,920123,462Nov 10 05:34 PM
DAMELIO FRANK AExecutive Vice PresidentNov 07Sale29.7807454,687Nov 10 05:34 PM
YOUNG JOHN DGroup PresidentNov 07Sale29.8921,600645,548101,862Nov 10 05:34 PM
READ IAN CChairman & CEOOct 30Option Exercise17.0354,585929,5831,465,906Nov 03 06:23 PM
DAMELIO FRANK AExecutive Vice PresidentOct 30Option Exercise17.0365,5021,115,499501,494Nov 03 06:23 PM
READ IAN CChairman & CEOOct 30Sale29.7667,5002,008,8001,358,862Nov 03 06:23 PM
MADDALUNA ANTHONY JExecutive Vice PresidentOct 29Sale29.562,42571,68388,987Oct 30 06:23 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Option Exercise26.2036,275950,40593,010Jun 13 12:29 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Sale29.5336,2751,071,27856,735Jun 13 12:29 PM
YOUNG JOHN DGroup PresidentMar 17Sale31.389,000282,42099,647Mar 18 09:33 AM
PFIZER INC10% OwnerMar 12Buy11.00272,7272,999,9971,235,330Mar 14 03:27 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale32.5967,5852,202,872173,637Mar 05 05:36 PM
Dolsten MikaelPresident R&DMar 04Sale32.5835,7891,165,929344,571Mar 05 05:36 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 04Sale32.555,082165,419171,756Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Option Exercise26.2075,5001,978,100274,699Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Sale32.0297,8613,133,674176,838Mar 05 05:37 PM
READ IAN CChairman & CEOFeb 26Option Exercise12.70324,9324,126,6361,410,536Feb 28 04:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise12.70130,8751,662,113312,499Feb 28 04:52 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise12.7057,586731,342116,884Feb 28 04:52 PM
BOURLA ALBERTGroup PresidentFeb 26Option Exercise12.7021,482272,82192,447Feb 28 04:52 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise12.7056,411716,420228,878Feb 28 04:52 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise12.70324,9324,126,636615,673Feb 28 04:52 PM
HILL CHARLES HExecutive Vice PresidentFeb 26Option Exercise12.7034,731441,084104,046Feb 28 04:52 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise12.7034,568439,014120,562Feb 28 04:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12740,480Feb 28 04:52 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12783,716Feb 28 04:52 PM
OLSON LAURIE JExecutive Vice PresidentFeb 26Option Exercise12.7031,772403,50468,167Feb 28 04:52 PM
PFIZER INC10% OwnerFeb 04Buy8.00227,2611,818,0881,794,803Feb 06 03:53 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.82131,8104,062,225356,451Jan 14 07:13 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.8628,190869,817328,261Jan 14 07:13 PM